Introduction
Although herbal medicinal products (HMP) have been perceived by the public as relatively low risk, there has been more recognition of the potential risks associated with this type of product as the use of HMPs increase. Potential harm can occur via inherent toxicity of herbs, as well as from contamination, plant misidentification, and interactions with other herbal products or pharmaceutical drugs. Regulatory safety assessment for HMPs relies on both the assessment of cases of adverse reactions and the review of published toxicity information. The submission of data on genotoxicity is a precondition for marketing authorization respectively registration of herbal medicinal products (HMPs) with well-established or traditional use in some countries. The assessment of potential genotoxicity of HMPs should describe a stepwise approach, including the possibility to reduce the number of extracts of an herbal drug to be tested by the use of more recent toxicological assessment techniques such as predictive toxicology and "omics". In the regulatory context, safety assessment can have bearing on whether certain products should be restricted, removed from the market, or have augmented safety information placed on labeling.
This chapter discusses the challenges which are faced in the assessment of safety of HMPs and the need for careful judgments on the hazard and risk of HMPs can be made with increased certainty. Hence, it is critical that toxicologists in industry, regulatory agencies and academic institutions develop a consensus, based on rigorous methods, about the reliability and interpretation of endpoints. It will also be important to regulate the integration of conventional methods for toxicity assessments with new "omics" technologies. The publisher is retracting and removing the above book chapter following a reader's report of significant overlap of text between the chapter and an article previously published in the Journal of Ethnopharmacology [1] . Subsequent investigation of the reader's allegations has confirmed the overlap, as well as uncovered additional instances of significant overlap of text between the chapter and other previously published articles [2] [3] [4] [5] [6] . All sources of text were cited in the chapter, but there was no adequate indication that the text was taken verbatim from those sources, nor were the necessary copyright permissions obtained for inclusion of the copied paragraphs. Even though the author of the chapter had no malicious intentions, this inevitably forms a basis for retraction and removal according to current publishing ethics conventions.
